FREE Account Opening + No Clearing Fees

Emcure Pharmaceuticals Limited IPO (Emcure Pharma IPO) Detail

July 3, 2024 - July 5, 2024

Emcure Pharma IPO is a book built issue of Rs 1,952.03 crores. The issue is a combination of fresh issue of 0.79 crore shares aggregating to Rs 800.00 crores and offer for sale of 1.14 crore shares aggregating to Rs 1,152.03 crores.

Emcure Pharma IPO bidding started from July 3, 2024 and ended on July 5, 2024. The allotment for Emcure Pharma IPO was finalized on Monday, July 8, 2024. The shares got listed on BSE, NSE on July 10, 2024.

Emcure Pharma IPO price band is set at ₹960 to ₹1008 per share. The minimum lot size for an application is 14 Shares. The minimum amount of investment required by retail investors is ₹14,112. The minimum lot size investment for sNII is 15 lots (210 shares), amounting to ₹211,680, and for bNII, it is 71 lots (994 shares), amounting to ₹1,001,952.

The issue includes a reservation of up to 108,900 shares for employees offered at a discount of Rs 90 to the issue price.

Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited and Jefferies India Private Limited are the book running lead managers of the Emcure Pharma IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Emcure Pharma IPO RHP for detailed information.

Emcure Pharma IPO Details

IPO Date July 3, 2024 to July 5, 2024
Listing Date July 10, 2024
Face Value ₹10 per share
Price Band ₹960 to ₹1008 per share
Lot Size 14 Shares
Total Issue Size19,365,346 shares
(aggregating up to ₹1,952.03 Cr)
Fresh Issue7,936,507 shares
(aggregating up to ₹800.00 Cr)
Offer for Sale11,428,839 shares of ₹10
(aggregating up to ₹1,152.03 Cr)
Employee Discount Rs 90 per share
Issue Type Book Built Issue IPO
Listing At BSE, NSE
Share holding pre issue180,852,116
Share holding post issue188,788,623

Emcure Pharma IPO Reservation

Emcure Pharma IPO offers 19,483,388 shares. 3,853,234 (19.78%) to QIB, 2,889,926 (14.83%) to NII, 6,743,160 (34.61%) to RII, 108,900 (0.56%) to employees and 5,779,850 (29.67%) to Anchor investors. 481,654 RIIs will receive minimum 14 shares and 4,587 (sNII) and 9,174 (bNII) will receive minimum 210 shares. (in case of oversubscription)

Investor Category Shares OfferedMaximum Allottees
Anchor Investor Shares Offered5,779,850 (29.67%)NA
QIB Shares Offered3,853,234 (19.78%)NA
NII (HNI) Shares Offered2,889,926 (14.83%)
  bNII > ₹10L1,926,618 (9.89%)9,174
  sNII < ₹10L963,309 (4.94%)4,587
Retail Shares Offered6,743,160 (34.61%)481,654
Employee Shares Offered108,900 (0.56%)NA
Total Shares Offered19,483,388 (100%)

Emcure Pharma IPO Anchor Investors Details

Emcure Pharma IPO raises Rs 582.61 crore from anchor investors. Emcure Pharma IPO Anchor bid date is July 2, 2024. Emcure Pharma IPO Anchor Investors list

Bid Date July 2, 2024
Shares Offered 5,779,850
Anchor Portion Size (In Cr.) 582.61
Anchor lock-in period end date for 50% shares (30 Days) August 7, 2024
Anchor lock-in period end date for remaining shares (90 Days) October 6, 2024

Emcure Pharma IPO Timeline (Tentative Schedule)

Emcure Pharma IPO opens on July 3, 2024, and closes on July 5, 2024.

IPO Open Date Wednesday, July 3, 2024
IPO Close Date Friday, July 5, 2024
Basis of Allotment Monday, July 8, 2024
Initiation of Refunds Tuesday, July 9, 2024
Credit of Shares to Demat Tuesday, July 9, 2024
Listing Date Wednesday, July 10, 2024
Cut-off time for UPI mandate confirmation 5 PM on July 5, 2024

Emcure Pharma IPO Lot Size

Investors can bid for a minimum of 14 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 14 ₹14,112
Retail (Max) 14 196 ₹197,568
S-HNI (Min) 15 210 ₹211,680
S-HNI (Max) 70 980 ₹987,840
B-HNI (Min) 71 994 ₹1,001,952
Lot Size Calculator

Emcure Pharma IPO Promoter Holding

Satish Mehta and Sunil Mehta are the company promoters.

Share Holding Pre Issue 98.90%
Share Holding Post Issue 78.24%

About Emcure Pharmaceuticals Limited

Incorporated in 1981, Emcure Pharmaceuticals Limited, an Indian pharmaceutical company, develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.

The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.

In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company's total revenue, respectively. The company's Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.

As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.

Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.

As of September 30, 2023, the company's marketing and distribution network in India was supported by over 5,000 field personnel who regularly interacted with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Profit After Tax527.58561.85702.56
Net Worth2,952.282,501.131,987.55
Reserves and Surplus2,722.402,293.771,791.03
Total Borrowing2,091.942,202.422,102.19
Amount in ₹ Crore

Key Performance Indicator

The market capitalization of Emcure Pharma IPO is Rs 19029.89 Cr.

KPI Values
Pre IPO Post IPO
EPS (Rs) 29.1727.95
P/E (x) 34.5536.07
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2024 that is available in RHP.

Objects of the Issue (Emcure Pharma IPO Objectives)

The Company proposes to utilise the Net Proceeds towards funding the following objects:
  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
  • General corporate purposes

Emcure Pharma IPO Review (Apply)

[Dilip Davda]  The company is one of the leading pharma company having niche products and serving global markets. It marked growth in its top lines, but bottom line posted declining trends due to higher interest and depreciation costs. Based on FY24 earnings, the issue appears fully priced. Reduction in debt post IPO will improved its bottom line commensurately. Investors may park funds for the medium to longer term. Read detail review...

Emcure Pharma IPO Subscription Status (Bidding Detail)

The Emcure Pharma IPO is subscribed 67.87 times on July 5, 2024 6:20:06 PM. The public issue subscribed 7.36 times in the retail category, 191.24 times in the QIB category, and 49.32 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
    bNII (bids above ₹10L)54.90
    sNII (bids below ₹10L)38.16

Total Application : 2,845,226 (5.91 times)

Emcure Pharma IPO Prospectus

Emcure Pharma IPO Rating

Rating:Rated 4.3 stars
Vote Here ...

Emcure Pharma IPO Listing Details

Listing Date July 10, 2024
BSE Script Code 544210
ISIN INE168P01015
Final Issue Price ₹1008 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Emcure Pharmaceuticals Limited Contact Details

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033

Emcure Pharma IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Emcure Pharma IPO FAQs

Emcure Pharma IPO is a main-board IPO of 19,365,346 equity shares of the face value of ₹10 aggregating up to ₹1,952.03 Crores. The issue is priced at ₹960 to ₹1008 per share. The minimum order quantity is 14 Shares.

The IPO opens on July 3, 2024, and closes on July 5, 2024.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Emcure Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Emcure Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Emcure Pharma IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Emcure Pharma IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Emcure Pharma IPO opens on July 3, 2024 and closes on July 5, 2024.

Emcure Pharma IPO lot size is 14 Shares, and the minimum amount required is ₹14,112.

You can apply in Emcure Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Emcure Pharma IPO will be done on Monday, July 8, 2024, and the allotted shares will be credited to your demat account by Tuesday, July 9, 2024. Check the Emcure Pharma IPO allotment status.

The Emcure Pharma IPO listing date is on July 10, 2024.
Open an Instant Account with Zerodha

Emcure Pharma IPO Message Board

Ranked Members of Forum  Ranked Members | Members with Most Likes